STOCK TITAN

Paragon 28 Announces Appointment of Meghan Scanlon to Board of Directors

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
management
Rhea-AI Summary

Paragon 28, Inc. (NYSE: FNA) has appointed Meghan Scanlon to its Board of Directors, enhancing its leadership team. With over 20 years in the medical device sector, Scanlon currently serves as senior vice president at Boston Scientific Corporation. She will also contribute to the Compensation and Quality, Technology and Regulatory Committees. Paragon 28 aims to improve outcomes for foot and ankle patients, focusing on innovative orthopedic solutions and procedural approaches.

Positive
  • Meghan Scanlon brings over 20 years of senior leadership experience in the medical device industry.
  • Her appointment is expected to enhance diversity and inclusion initiatives within the company.
  • Scanlon's background in global device markets could strengthen Paragon 28's strategic direction.
Negative
  • Concerns may arise regarding continuity and integration of Scanlon into the Board dynamics due to her previous commitments.

ENGLEWOOD, Colo.--(BUSINESS WIRE)-- Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, announced today the appointment of Meghan Scanlon to its Board of Directors. Ms. Scanlon has joined the Board’s Compensation and Quality, Technology and Regulatory Committees. Ms. Scanlon has more than 20 years of senior leadership experience with global medical device companies. She currently serves as senior vice president and president, Urology and Pelvic Health, for Boston Scientific Corporation and is a member of the Boston Scientific Executive Committee. Ms. Scanlon also is a member of the Boston Scientific Global Council for Inclusion, serving as the executive sponsor for the PRIDE employee resource group.

“We are very excited to have Meghan join our Board of Directors,” said Albert DaCosta, CEO and Chairman of Paragon 28. “Meghan is a seasoned global medical device executive with an impressive track record of success. Meghan is also a champion for diversity and inclusion. I look forward to partnering with Meghan to advance our mission of improving foot and ankle patient outcomes.”

Prior to Boston Scientific, Ms. Scanlon worked at DePuy Synthes, the orthopaedics company of Johnson & Johnson, from July 2000 to September 2014. Ms. Scanlon holds a B.S. in Mechanical Engineering from Tufts University, and both a M.B.A and a M.S. in Mechanical Engineering from the Massachusetts Institute of Technology.

About Paragon 28, Inc.

Based in Englewood, Colo., Paragon 28, is a leading medical device company exclusively focused on the foot and ankle orthopedic market and is dedicated to improving patient lives. From the onset, Paragon 28® has provided innovative orthopedic solutions, procedural approaches and instrumentation that cover a wide range of foot and ankle ailments including fracture fixation, hallux valgus (bunions), hammertoe, ankle, progressive collapsing foot deformity (PCFD) or flatfoot, charcot foot and orthobiologics. The company designs products with both the patient and surgeon in mind, with the goal of improving outcomes, reducing ailment recurrence and complication rates, and making the procedures simpler, consistent, and reproducible.

Investor Contact:

Gilmartin Group

Matt Bacso, CFA

matt.bacso@gilmartinir.com

Source: Paragon 28, Inc.

FAQ

Who is Meghan Scanlon and what role will she play at Paragon 28?

Meghan Scanlon has been appointed to the Board of Directors of Paragon 28, Inc. She will serve on the Compensation and Quality, Technology and Regulatory Committees.

What experience does Meghan Scanlon have in the medical device industry?

Meghan Scanlon has over 20 years of experience, including her current role as senior vice president at Boston Scientific Corporation.

How might Meghan Scanlon's appointment impact Paragon 28?

Scanlon's extensive experience could potentially enhance Paragon 28's strategic initiatives and improve diversity within the Board.

What is the stock symbol for Paragon 28?

The stock symbol for Paragon 28 is FNA.

Paragon 28, Inc.

NYSE:FNA

FNA Rankings

FNA Latest News

FNA Stock Data

469.51M
83.54M
40.68%
60%
8.17%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
ENGLEWOOD